I

Immuron Limited
D

IMRN

1.86000
USD
-0.09
(-4.62%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-2
Market Cap
10,601,924
Related Instruments
News

Title: Immuron Limited

Sector: Healthcare
Industry: Biotechnology
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.